Amanda Van Swearingen

Publications

Zimmer, Alexandra S., Amanda E. D. Van Swearingen, and Carey K. Anders. “HER2-positive breast cancer brain metastasis: A new and exciting landscape.” Cancer Reports (Hoboken, N.J.), September 3, 2020, e1274. https://doi.org/10.1002/cnr2.1274.

PMID
32881421
Full Text

Sammons, Sarah, Amanda E. D. Van Swearingen, and Carey K. Anders. “Receptor discordance in breast cancer brain metastases: when knowledge is power.” Neuro Oncol 22, no. 8 (August 17, 2020): 1060–61. https://doi.org/10.1093/neuonc/noaa131.

PMID
32479604
Full Text

Valiente, Manuel, Amanda E. D. Van Swearingen, Carey K. Anders, Amos Bairoch, Adrienne Boire, Paula D. Bos, Diana M. Cittelly, et al. “Brain Metastasis Cell Lines Panel: A Public Resource of Organotropic Cell Lines.” Cancer Research, July 8, 2020. https://doi.org/10.1158/0008-5472.can-20-0291.

PMID
32641416
Full Text

Vinod, Natasha, Duhyeong Hwang, Salma H. Azam, Amanda E. D. Van Swearingen, Elizabeth Wayne, Sloane Christian Fussell, Marina Sokolsky-Papkov, Chad V. Pecot, and Alexander V. Kabanov. “High-capacity poly(2-oxazoline) formulation of TLR 7/8 agonist extends survival in a chemo-insensitive, metastatic model of lung adenocarcinoma.” Science Advances 6, no. 25 (June 17, 2020): eaba5542. https://doi.org/10.1126/sciadv.aba5542.

PMID
32596460
Full Text

Leslie, Patrick L., Yvonne L. Chao, Yi-Hsuan Tsai, Subrata K. Ghosh, Alessandro Porrello, Amanda E. D. Van Swearingen, Emily B. Harrison, et al. “Histone deacetylase 11 inhibition promotes breast cancer metastasis from lymph nodes.” Nature Communications 10, no. 1 (September 13, 2019): 4192. https://doi.org/10.1038/s41467-019-12222-5.

PMID
31519896
Full Text

Van Swearingen, Amanda E. D., Marni B. Siegel, Allison M. Deal, Maria J. Sambade, Alan Hoyle, D Neil Hayes, Heejoon Jo, et al. “LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.” Breast Cancer Research and Treatment 171, no. 3 (October 2018): 637–48. https://doi.org/10.1007/s10549-018-4852-5.

PMID
29938395
Full Text

Pecot, C., A. Van Swearingen, and B. Papke. “MA27.06 Therapeutic Silencing of Oncogenic KRAS With a Mutant-Specific Short Interfering RNA.” In Journal of Thoracic Oncology, 13:S456–S456. Elsevier BV, 2018. https://doi.org/10.1016/j.jtho.2018.08.551.

Full Text

Sambade, Maria, Amanda Van Swearingen, Kaiming Sun, Jing Wang, Kevin Mikule, and Carey K. Anders. “Abstract 2813: Efficacy and pharmacokinetics of niraparib inBRCA-mutant and wild-type intracranial triple negative breast cancer murine models.” In Experimental and Molecular Therapeutics. American Association for Cancer Research, 2018. https://doi.org/10.1158/1538-7445.am2018-2813.

Full Text

Siegel, Marni B., Xiaping He, Katherine A. Hoadley, Alan Hoyle, Julia B. Pearce, Amy L. Garrett, Sunil Kumar, et al. “Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer.” The Journal of Clinical Investigation 128, no. 4 (April 2018): 1371–83. https://doi.org/10.1172/jci96153.

PMID
29480819
Full Text

Pages